P&K Skin Research Center Co. Ltd (347740) — Capital Reinvestment Ratio
P&K Skin Research Center Co. Ltd (347740) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.70 Billion) in capital expenditures (₩281.11 Million). See 347740 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
P&K Skin Research Center Co. Ltd Capital Reinvestment Ratio (2018–2024)
This chart tracks P&K Skin Research Center Co. Ltd's Capital Reinvestment Ratio across 7 annual periods. Check 347740 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for P&K Skin Research Center Co. Ltd (2018–2024)
Year-by-year Capital Reinvestment Ratio for P&K Skin Research Center Co. Ltd from 2018 to 2024. For live market cap and broader valuation context, see market value of P&K Skin Research Center Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩9.03 Billion | ₩622.12 Million | ▼ -75.5% |
| 2023 | 0.28x | ₩5.55 Billion | ₩1.56 Billion | ▲ +55.6% |
| 2022 | 0.18x | ₩7.51 Billion | ₩1.36 Billion | ▼ -50.5% |
| 2021 | 0.37x | ₩7.70 Billion | ₩2.81 Billion | ▲ +200.0% |
| 2020 | 0.12x | ₩8.67 Billion | ₩1.05 Billion | ▲ +46.0% |
| 2019 | 0.08x | ₩6.49 Billion | ₩541.19 Million | ▼ -45.8% |
| 2018 | 0.15x | ₩4.26 Billion | ₩655.80 Million | — |